Evaluation of the Immuno-Stimulatory Potential (Shareera Bala) of an Ayurveda Management Protocol in Cohort of Quarantined Delhi Police under Covid-19 Care Centers- An Exploratory Clinical Study

Evaluation of the Immuno- stimulatory Potential (Shareera Bala) of an Ayurveda management protocol in Cohort of Quarantined Delhi police under Covid-19 care centers- An Exploratory clinical study - APCOVIDA

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/05/025178

Enrollment

140

Registered

2020-05-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: group-A: 1. TabSamshamani Vati 250 mg 2 bid after food with water for 60 days 2. Herbal tea â?? 150 ml in the morning once daily for 60 days( Preparation of Herbal tea: Boil 150 ml (1

Eligibility

Inclusion criteria

Inclusion criteria: 1.Available police personnel of either sex aged 19-60 years 2.Delhi Police personnel quarantined for COVID-19 infection. 3.Agrees not to self-medicate with chloroquine, hydroxychloroquine or other potential antivirals. 4.Individuals agree to give consent for participation

Exclusion criteria

Exclusion criteria: 1.Individuals with uncontrolled co morbid conditions which may affect the Bala of the Individual. 2.Already suffering with severe respiratory allergies and other conditions which may create bias in the outcome results 3.Individuals found positive for COVID 19 during the course of medication. Defined as: temperature > 38 Celsius; cough; shortness of breath; sore throat; or, if available (not required), positive confirmatory testing for COVID-19 4.Previously diagnosed with COVID-19 5.Subjects on other prophylactic medications. 6.Concurrent condition that in the investigatorâ??s opinion would jeopardize compliance with the protocol.

Design outcomes

Primary

Measure	Time frame
Improvement in Bala of an individual Immuno-stimulation leading to non-development of symptoms of CoVID-19 in risk population exposed to infected individuals. (Bala will be assessed by using specialised proforma including dashavidha pareeksha and other questionnaires which will reveal the physical and mental health of an individual.)Timepoint: Baseline, 15th day, 30th day, 45th day, 60th day and 90th day	—

Measure

Time frame

Improvement in Bala of an individual Immuno-stimulation leading to non-development of symptoms of CoVID-19 in risk population exposed to infected individuals. (Bala will be assessed by using specialised proforma including dashavidha pareeksha and other questionnaires which will reveal the physical and mental health of an individual.)Timepoint: Baseline, 15th day, 30th day, 45th day, 60th day and 90th day

—

Secondary

Measure	Time frame
Improvement in quality of life( SF-36 per forma will be used)Timepoint: 12 week	—

Countries

India

Contacts

Public ContactDr VG Huddar

All India Institute Of Ayurveda

dr.vghuddar@aiia.gov.in9986697942

Outcome results